Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
View ORCID ProfileJ Loske, J Röhmel, View ORCID ProfileS Lukassen, S Stricker, VG Magalhães, J Liebig, RL Chua, L Thürmann, M Messingschlager, A Seegebarth, B Timmermann, S Klages, View ORCID ProfileM Ralser, B Sawitzki, LE Sander, View ORCID ProfileVM Corman, C Conrad, S Laudi, M Binder, S Trump, R Eils, M.A. Mall, I Lehmann
doi: https://doi.org/10.1101/2021.06.24.21259087
J Loske
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
J Röhmel
2Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany
S Lukassen
3Center for Digital Health, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
S Stricker
2Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany
VG Magalhães
4Research group “Dynamics of Early Viral Infection and the Innate Antiviral Response”, division F170, German Cancer Research Center (DKFZ), Heidelberg, Germany
J Liebig
3Center for Digital Health, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
RL Chua
3Center for Digital Health, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
L Thürmann
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
M Messingschlager
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
A Seegebarth
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
B Timmermann
5Max Planck Institute for Molecular Genetics, Berlin, Germany
S Klages
5Max Planck Institute for Molecular Genetics, Berlin, Germany
M Ralser
6Institute of Biochemistry, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
B Sawitzki
7Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
LE Sander
8Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
12German Center for Lung Research (DZL), associated partner, Berlin, Germany
VM Corman
9Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
10German Centre for Infection Research (DZIF), Associated Partner Charité-Universitätsmedizin Berlin, Berlin, Germany
C Conrad
3Center for Digital Health, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
S Laudi
11Department of Anesthesiology and Intensive Care, University Hospital Leipzig, Leipzig, Germany
M Binder
4Research group “Dynamics of Early Viral Infection and the Innate Antiviral Response”, division F170, German Cancer Research Center (DKFZ), Heidelberg, Germany
S Trump
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
R Eils
3Center for Digital Health, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
12German Center for Lung Research (DZL), associated partner, Berlin, Germany
13Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
M.A. Mall
2Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany
12German Center for Lung Research (DZL), associated partner, Berlin, Germany
I Lehmann
1Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany
12German Center for Lung Research (DZL), associated partner, Berlin, Germany
13Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
Data Availability
Due to potential risk of de-identification of pseudonymized RNA sequencing data the raw data will be available under controlled access in the EGA repository, [will be added upon completion of peer review/ acceptance]. Count and metadata tables (patient-ID, sex, age, cell type, QC metrics per cell) can be found at FigShare: [will be added upon completion of peer review/ acceptance]. In addition, these data can be further visualized and analyzed in the Magellan COVID-19 data explorer at https://digital.bihealth.org [will be publicly available upon completion of peer review/ acceptance].
Posted June 28, 2021.
Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, RL Chua, L Thürmann, M Messingschlager, A Seegebarth, B Timmermann, S Klages, M Ralser, B Sawitzki, LE Sander, VM Corman, C Conrad, S Laudi, M Binder, S Trump, R Eils, M.A. Mall, I Lehmann
medRxiv 2021.06.24.21259087; doi: https://doi.org/10.1101/2021.06.24.21259087
Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, RL Chua, L Thürmann, M Messingschlager, A Seegebarth, B Timmermann, S Klages, M Ralser, B Sawitzki, LE Sander, VM Corman, C Conrad, S Laudi, M Binder, S Trump, R Eils, M.A. Mall, I Lehmann
medRxiv 2021.06.24.21259087; doi: https://doi.org/10.1101/2021.06.24.21259087
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2150)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)